Effects of cAMP and cGMP on L-type calcium channel currents in rat mesenteric artery cells

Jpn J Pharmacol. 1997 Jun;74(2):179-86. doi: 10.1254/jjp.74.179.

Abstract

L-type Ca2+ channel currents in cultured rat mesenteric artery smooth muscle cells were recorded by the cell-attached patch-clamp technique. Depolarizing voltage steps from a holding potential of -40 mV elicited voltage-dependent inward Ba2+ currents. The inward currents were inhibited by nifedipine (10 microM) but enhanced by Bay K 8644 (5 microM), which suggests that the inward currents are carried almost exclusively by L-type Ca2+ channels. Application of dibutyryl cAMP (0.1-1 microM) and forskolin (0.01-1 microM) enhanced the activity of these Ca2+ channels. The dibutyryl cAMP induced enhancement of Ca2+ channels was antagonized by the serine/threonine kinase inhibitor H-8 (1 microM). Application of 8-bromo-cGMP (0.01-1 microM) and the cGMP inducer nitroglycerin (0.01-1 microM) inhibited the activity of these Ca2+ channels, and the inhibition of channel activity induced by 8-bromo-cGMP was antagonized by the serine/threonine kinase inhibitor H-8 (1 microM). These results suggest that in rat mesenteric artery cells, the L-type Ca2+ channel current is enhanced by a rise in intracellular cAMP levels and suppressed by a rise in intracellular cGMP levels. Furthermore, cGMP-induced Ca2+ channel inhibition may play a role in the expression of the nitric oxide-mediated vasodilating action of drugs such as nitroglycerin and atrial natriuretic peptide.

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Animals
  • Bucladesine / pharmacology
  • Calcium Channel Agonists / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Colforsin / pharmacology
  • Cyclic AMP / pharmacology*
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology*
  • In Vitro Techniques
  • Isoquinolines / pharmacology
  • Male
  • Membrane Potentials / drug effects
  • Mesenteric Arteries / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • Nifedipine / pharmacology
  • Nitroglycerin / pharmacology
  • Patch-Clamp Techniques
  • Rats
  • Rats, Wistar

Substances

  • Calcium Channel Agonists
  • Calcium Channel Blockers
  • Calcium Channels
  • Isoquinolines
  • Colforsin
  • 8-bromocyclic GMP
  • Bucladesine
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
  • Cyclic AMP
  • Nitroglycerin
  • Cyclic GMP
  • Nifedipine